Testing the CRISPR-Cas9 and glmS ribozyme systems in Leishmania tarentolae
Gino L. Turra, Luzia Schneider, Linda Liedgens, Marcel Deponte
The paper tests CRISPR-Cas9 and glmS ribozyme systems for gene disruption and knock-down in Leishmania tarentolae, finding success with CRISPR-Cas9 and limited effectiveness with glmS.
Molecular and Biochemical Parasitology · Nov 6, 2020Peer-reviewedGenetics